SCHEMBL23317664

SCHEMBL23317664

CCCC[PH](CCCC)(CCCC)C(CC)C(=O)Nc1c(C)cccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.42
HSP90AA1 P07900 1/20 0.42
SCN3A Q9NY46 4/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
SCN1A P35498 3/20 0.41
SCN2A Q99250 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP3A4 P08684 2/20 0.41
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23317287 0.90 ATM (0.41) ATMHSP90AA1SCN3AMAPTLMNA
SCHEMBL23317381 0.86 HPGD (0.44) LMNACYP2C9ALDH1A1NLRP3POLB
SCHEMBL23294937 0.85 ATM (0.46) ATMHSP90AA1SCN3AMAPTLMNA
SCHEMBL23317391 0.84 ATM (0.46) ATMHSP90AA1SCN3AMAPTLMNA
SCHEMBL23317424 0.84 HPGD (0.39) MAPTLMNAMEN1KMT2ACYP1A2
SCHEMBL23317194 0.84 HPGD (0.35) MAPTLMNACYP2C9ALDH1A1CYP2D6
Bicarbonate SCHEMBL23294944 0.83 ATM (0.47) ATMHSP90AA1SCN3AMAPTLMNA
SCHEMBL23317624 0.82 CYP3A4 (0.37) MAPTKMT2ACYP3A4ALDH1A1ALOX15
SCHEMBL23317156 0.81 ATM (0.47) ATMHSP90AA1SCN3AMAPTLMNA
SCHEMBL23317581 0.81 ALDH1A1 (0.39) MAPTLMNAALDH1A1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701370-B2 Phosphonium ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-18 US disclosed
US-11701370-B2 Phosphonium ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-18 US disclosed
US-20210128589-A1 PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210128589-A1 PHOSPHONIUM ION CHANNEL BLOCKERS AND METHODS FOR USE TRPV1, TRPV5, TRPA1 ATM 4286/4885HSP90AA1 3207/4885SCN3A 101/4885
US-11701370-B2 Phosphonium ion channel blockers and methods for use TRPV1, TRPV5, TRPA1 ATM 4286/4885HSP90AA1 3207/4885SCN3A 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.